Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Levofloxacin not cost saving in CAP?

    • 8 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Levofloxacin not cost saving in CAP?. Pharmacoecon. Outcomes News 246, 5 (2000). https://doi.org/10.1007/BF03266785

    Download citation

    Keywords

    • Cost Saving
    • Ceftriaxone
    • Doxycycline
    • Levofloxacin
    • Wholesale Price